Role of CD40 ligand signaling in defective type 1 cytokine response in human immunodeficiency virus infection

Journal of Infectious Diseases

Volumn 183, Issue 12, 2001, Pages 1722-1731

  Subauste, C S ^a   Wessendarp, M ^a   Smulian, A G ^a   Frame, P T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; LIGAND;

ANTIGEN PRESENTING CELL; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TOXOPLASMA GONDII;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CD4 LYMPHOCYTE COUNT; CD40 LIGAND; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; TOXOPLASMA; TOXOPLASMOSIS; VIRAL LOAD;

EID: 0035877102     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320734     Document Type: Article

References (60)

1. Molecular and biological characterization of a murine ligand for CD40
2. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity
3. CD40 and CD154 in cell-mediated immunity
4. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40
5. Activation of human dendritic cells through CD40-cross-linking
6. - T-helper and a T-killer cell
7. Clinical spectrum of X-linked hyper-IgM syndrome
8. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: Patients with hyper IgM syndrome have a defective type-I immune response which can be restored by soluble CD40L trimer
9. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome
10. Impaired interleukin-12 production in human immunodeficiency virus-infected patients
11. + cell numbers and clinical staging
12. HIV infection suppresses type l lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines
13. + T helper cell depletion occurs
14. - T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus
15. + T cell counts
16. αβ T cell response to Toxoplasma gondii in previously unexposed individuals
17. Human dendritic cells discriminate between viable and killed Toxoplasma gondii tachyzoites: Dendritic cell activation after infection with viable parasites results in CD28 and CD40 ligand signaling that controls IL-12-dependent and -independent T cell production of IFN-γ
18. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40
19. Sensitized lymphocytes and CD40 ligation augment interleukin-12 production by human dendritic cells in response to Toxoplasma gondii
20. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L: Potential role in regulating helper effector function
21. CD40 ligand and IFN-γ synergistically restore IL-12 production in HIV-infected patients
22. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection
23. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus
24. Priming with IFN-γ restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors
25. Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production
26. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production
27. The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients
28. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes
29. CD40 ligand is required for protective cell-mediated immunity to Leishmania major
30. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages
31. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction
32. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii
33. IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii
34. Requirement for CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice
35. Role of CD40 ligand in Mycobacterium avium infection
36. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis
37. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice
38. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis
39. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum
40. CD40-CD40 ligand interactions augment survival of normal mice, but not CD40 ligand knockout mice, challenged orally with Salmonella dublin
41. - T cells and CD40
42. - T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
43. + individuals to express CD40 ligand after in vitro stimulation is not impaired
44. Functional B cell abnormalities in HIV type I infection: Role of CD40L and CD70
45. + T cells that induces contact-dependent B cell differentiation (help)
46. Measurement of CD69 induction in the assessment of immune function in asymptomatic HIV-infected individuals
47. + cells in IgE production
48. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
49. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia
50. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type I infection: Functional and clinical correlations
51. Regulation of CD40 ligand expression on naive CD4 T cells: A role for TCR but not co-stimulatory signals
52. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells
53. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells
54. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals
55. Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2
56. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
57. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
58. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-infection
59. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy
60. CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens